Finance

Lists
RUBICON:NSE
Rubicon Research Ltd
₹1 571,00
-1,62%
(-25,80) 1D
7 Okt., 09:43:48 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RUBICON...
Open
₹1 596,80
High
₹1 596,80
Low
₹1 566,10
Mkt. cap
263,67 mjd
Avg. vol.
284,69 k
Volume
26,43 k
Dividend
0,10%
Quarterly dividend
₹0,37
Ex-dividend date
07 Aug. 2026
P/E ratio
90,01
52-wk high
₹1 899,00
52-wk low
₹570,75
EPS
₹17,45
No. of employees
1 k
Open
₹1 596,80
High
₹1 596,80
Low
₹1 566,10
Mkt. cap
263,67 mjd
Avg. vol.
284,69 k
Volume
26,43 k
Dividend
0,10%
Quarterly dividend
₹0,37
Ex-dividend date
07 Aug. 2026
P/E ratio
90,01
52-wk high
₹1 899,00
52-wk low
₹570,75
EPS
₹17,45
No. of employees
1 k
News stories
From web sources and news partners
Profile
Rubicon Research is an Indian pharmaceutical company located in Mumbai. The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
About Rubicon Research Ltd
CEO-
Employees1,29 k
Founded1999
Headquarters-
SectorPharmaceutical industry
Last report
14 Aug. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹5,08 / ₹4,40
+15,45%beat
Revenue / Est. (INR)
5,34 mjd / 5,13 mjd
+4,20%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
4,12 mjd
4,76 mjd
5,14 mjd
5,34 mjd
Cost of goods sold
1,27 mjd
1,57 mjd
1,86 mjd
1,69 mjd
Cost of revenue
1,27 mjd
1,57 mjd
1,86 mjd
1,69 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
633,59 m
663,73 m
699,04 m
856,66 m
Operating expense
2,03 mjd
2,22 mjd
2,21 mjd
2,51 mjd
Total operating expenses
3,30 mjd
3,79 mjd
4,07 mjd
4,20 mjd
Operating income
824,26 m
965,73 m
1,06 mjd
1,14 mjd
Other non operating income
6,97 m
37,87 m
-157,07 m
56,83 m
EBT including unusual items
717,05 m
905,86 m
986,87 m
1,10 mjd
EBT excluding unusual items
717,05 m
905,86 m
996,82 m
1,10 mjd
Income tax expense
178,53 m
177,89 m
219,02 m
255,91 m
Effective tax rate
24,90%
19,64%
22,19%
23,19%
Other operating expenses
1,28 mjd
1,44 mjd
1,39 mjd
1,51 mjd
Net income
538,52 m
727,97 m
767,85 m
847,81 m
Net profit margin
13,07%
15,31%
14,94%
15,87%
Earnings per share
3,47
4,41
4,60
5,08
Interest and investment income
-
-
79,68 m
-
Interest expense
-114,18 m
-97,74 m
-
-92,88 m
Net interest expenses
-114,18 m
-97,74 m
79,68 m
-92,88 m
Depreciation and amortization charges
118,71 m
115,53 m
122,66 m
151,39 m
EBITDA
976,82 m
1,12 mjd
1,14 mjd
1,21 mjd
Gain or loss from assets sale
7,63 m
-
-
-
AI content may include mistakes. Learn more
Google-programme